Qingdao Haier Biomedical Co Ltd
Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, transport coolers, and RTMD products; and CO2 in… Read more
Qingdao Haier Biomedical Co Ltd - Asset Resilience Ratio
Qingdao Haier Biomedical Co Ltd (688139) has an Asset Resilience Ratio of 14.11% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Qingdao Haier Biomedical Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Qingdao Haier Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥792.04 Million | 14.11% |
| Total Liquid Assets | CN¥792.04 Million | 14.11% |
Asset Resilience Insights
- Moderate Liquidity: Qingdao Haier Biomedical Co Ltd has 14.11% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Qingdao Haier Biomedical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Qingdao Haier Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Qingdao Haier Biomedical Co Ltd (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Qingdao Haier Biomedical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 15.16% | CN¥877.25 Million | CN¥5.79 Billion | +3.37pp |
| 2023-12-31 | 11.78% | CN¥651.14 Million | CN¥5.53 Billion | -25.08pp |
| 2022-12-31 | 36.87% | CN¥2.02 Billion | CN¥5.49 Billion | -6.60pp |
| 2021-12-31 | 43.47% | CN¥2.13 Billion | CN¥4.90 Billion | +33.12pp |
| 2020-12-31 | 10.35% | CN¥408.03 Million | CN¥3.94 Billion | +5.97pp |
| 2019-12-31 | 4.38% | CN¥133.05 Million | CN¥3.04 Billion | -- |